Massachusetts Rx
Executive Summary
Massachusetts may suspend its Rx drug insurance program Prescription Advantage April 1 if its waiver request is not approved by the Centers for Medicare & Medicaid Services. The waiver would reimburse the state for half the costs of the $100 mil.-a-year drug program; 80,000 seniors are enrolled (1"The Pink Sheet" April 9, 2001, p. 17). Massachusetts plans to develop a new senior drug discount program by the end of March...
You may also be interested in...
Massachusetts To Assume Risk In Rx Insurance Contract With AdvancePCS
Massachusetts will serve as the risk-bearing entity in its contract with the pharmacy benefit manager AdvancePCS for the state's prescription drug insurance program.
Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: